Filing Details
- Accession Number:
- 0001127602-20-018077
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-28 18:02:08
- Reporting Period:
- 2020-05-26
- Accepted Time:
- 2020-05-28 18:02:08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1682852 | Moderna Inc. | MRNA | Biological Products, (No Disgnostic Substances) (2836) | 813467528 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1760669 | Stephen Hoge | C/O Moderna, Inc. 200 Technology Square Cambridge MA 02139 | President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-05-26 | 1,045 | $57.75 | 2,005,495 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-05-26 | 100 | $58.72 | 2,005,395 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-05-26 | 1,182 | $60.77 | 2,004,213 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-05-26 | 3,763 | $61.61 | 2,000,450 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-05-26 | 1,910 | $62.54 | 1,998,540 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-05-26 | 1,000 | $63.97 | 1,997,540 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-05-26 | 800 | $64.94 | 1,996,740 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-05-26 | 200 | $66.11 | 1,996,540 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 4,116 | Indirect | By Valhalla, LLC |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $57.38 to $58.26. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.07 to $61.01. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $61.08 to $62.07. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.09 to $63.09. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.46 to $64.36. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.65 to $65.15. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.